Influence of infection on exacerbations of multiple sclerosis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Exacerbations of multiple sclerosis (MS) are triggered by exogenous events, the best documented being viral upper respiratory infections (URIs), which can stimulate secretion of cytokines such as interferon-gamma (IFN-gamma) by immune cells. In conjunction with a recent clinical trial of systemic interferon-beta (IFN-beta) in relapsing-remitting MS, we studied the occurrence of viral infections and their correlation with MS attacks. Thirty patients kept daily logs, noting URI symptoms in themselves, family members, and co-workers. Patients were examined every 3 months, or whenever an attack of MS occurred, and were tested for antibodies to common upper respiratory pathogens. A strong correlation was found between MS attacks and URIs. There were 168 URIs in 2,792 patient-weeks, including 996 weeks at risk (the interval beginning 1 week before and ending 5 weeks after onset of URI symptoms) and 1,796 weeks not at risk. Nearly two-thirds of attacks occurred in periods at risk. Attack rates were 2.92 per year in weeks at risk compared to 1.16 per year in weeks not at risk, a significant difference (p < 0.001). High-dose interferon reduced the frequency of MS attacks, but had no effect on the number of URIs. Although a specific virus could not be incriminated, we concluded that URIs of presumed viral origin are an important trigger of MS attacks, and that treatment with IFN-beta reduces the attack rate, but not by preventing URIs. Rather, it may modulate responses to viral infection that would otherwise lead to immune activation and clinical symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.655 · Cited by 2,085
Girard, M., Duquette, P., & Sibley, W. A. (1993) · Cited by 1,196
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071
Self-citationCLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 594
Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H., & Wietzerbin, J. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03663.x · Cited by 405
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study
Andersen, O., Lygner, P.-E., Bergstr�m, T., Andersson, M., & Vablne, A. (1993) · Journal of Neurology · doi:10.1007/bf00867354 · Cited by 265
The Diagnosis of Multiple Sclerosis
Ho, S. U. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03350370133041 · Cited by 160
Cited by
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
TLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734
Molecular mimicry and immune‐mediated diseases
Oldstone, M. B. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1255 · Cited by 599
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Neuroinvasion by Human Respiratory Coronaviruses
Arbour, N., Day, R., Newcombe, J., & Talbot, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8913-8921.2000 · Cited by 522
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
Soldan, S. S., Berti, R., Salem, N., Secchiero, P., Flamand, L., Calabresi, P. A., Brennan, M. B., Maloni, H. W., Mcfarland, H. F., Lin, H.-C., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1394 · Cited by 445
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
“The results of other studies also provide evidence that viral infections increase the chances of relapse, although the effects were smaller in these studie”
ResultProspective study on the relationship between infections and multiple sclerosis exacerbations
Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van der Meché, F. G. A., van Doorn, P. A., & Hintzen, R. Q. (2002) · Brain · doi:10.1093/brain/awf098 · Cited by 427
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
The initiation and prevention of multiple sclerosis
Ascherio, A., Munger, K. L., & Lünemann, J. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.198 · Cited by 289
Rare diseases bullet 7: Pleuropulmonary manifestations of systemic lupus erythematosus
Keane, M. P. (2000) · Thorax · doi:10.1136/thorax.55.2.159 · Cited by 276
Smouldering multiple sclerosis: the ‘real MS’
Giovannoni, G., Popescu, V., Wuerfel, J., Hellwig, K., Iacobaeus, E., Jensen, M. B., García-Domínguez, J. M., Sousa, L., De Rossi, N., Hupperts, R., et al. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211066751 · Cited by 271
The risk of relapses in multiple sclerosis during systemic infections
Correale, J., Fiol, M., & Gilmore, W. (2006) · Neurology · doi:10.1212/01.wnl.0000233834.09743.3b · Cited by 256
Molecular Mimicry, Microbial Infection, and Autoimmune Disease: Evolution of the Concept
Oldstone, M. B. A. (2005) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-30791-5_1 · Cited by 146
“, were complemented by epidemiological evidence incriminating local events (geography) or multiple infections with these diseases (Eastmond and Woodrow 1977; Ebers et al. 1987; Gamble 1980; Green 1990; Jury et al. 1996; Kurtzke 1993; Merriman and Todd 1995; Panitch 1994; Theofilopoulos 1995).”
BackgroundInfluentialTallantyre, E. C., Causon, E. G., Harding, K. E., Pickersgill, T. P., & Robertson, N. P. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514538333 · Cited by 18
Metadata
- Authors
- Panitch, H. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994
- Volume
- 36
- Issue
- S1
- Pages
- S25-S28
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2093942918
- Cited by
- 276
- References
- 8
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.